Establishing Sustainable Access to Quality Uterotonics in Kano, Lagos and Niger States—A Supply Chain Perspective
The International Journal of Health Planning and Management · 2025
DOI: 10.1002/hpm.3910 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Health Planning and Management, 2025. Verfasst von Eba Ajima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Solina Centre for International Development and Research (SCIDaR), Abuja, Nigeria. Hauptthemen laut MEDLINE: Oxytocics, Oxytocin, Health Services Accessibility, Misoprostol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Sharp and Dohme.
Abstract (Originalsprache)
Background
The quality of oxytocin and misoprostol, the most widely used uterotonics for postpartum haemorrhage (PPH) management, suffer supply chain challenges and climactic susceptibilities.
Aim
To describe a supply chain strengthening programme for introducing heat‐stable Carbetocin (HSC), to health facilities in Kano, Lagos and Niger states.
Method
Human‐centred design (HCD) was employed to uncover uterotonics supply chain challenges and to identify priority interventions across a market‐shaping value chain to facilitate the rollout of HSC. Through a mixed‐methods approach and interviews with 203 stakeholders, challenges in the uterotonics supply chain and potential solutions were identified. A market‐shaping value chain was employed to map HSC introduction and rollout, focusing on key interventions. Before the project initiation, we established clear objectives including identifying barriers, introduction and rollout journey mapping of HSC.
Results
Using HCD, HSC was successfully rolled out to over 87 health facilities. Employing the market‐shaping value chain, pivotal interventions were executed. These included policy updates (inclusion of HSC in the National and States Essential Medicines List), regulatory actions (registering Carbetocin with NAFDAC), financing strategies (co‐developing state roadmaps for sustainable procurements), supply management (reducing stock‐outs) and healthcare provider training on supply chain management practices. These efforts facilitated seamless integration of HSC into the states' supply chains.
Conclusion
HCD and market‐shaping value chain approach were employed to introduce HSC in Nigeria. This study shows that integrating these approaches can enhance the availability and accessibility of essential medicines, offering potential replicability in similar health systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Solina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.
- Clinton Health Access Initiative (CHAI), Boston, Massachusetts, USA.
ORCID-Profile: Eric Aigbogun, Valentine Amasiatu
Förderung
- Merck Sharp and Dohme
Zitieren
APA
Ajima, E., Nwaokorie, C., Kangkum, N., Ameyan, L., Ogefere, O. S., Aigbogun, E., Amasiatu, V., & Igbokwe, U. (2025). Establishing Sustainable Access to Quality Uterotonics in Kano, Lagos and Niger States—A Supply Chain Perspective. The International Journal of Health Planning and Management. https://doi.org/10.1002/hpm.3910
Vancouver
Ajima E, Nwaokorie C, Kangkum N, Ameyan L, Ogefere OS, Aigbogun E, et al. Establishing Sustainable Access to Quality Uterotonics in Kano, Lagos and Niger States—A Supply Chain Perspective. The International Journal of Health Planning and Management. 2025. doi:10.1002/hpm.3910
BibTeX
@article{Ajima2025,
author = {Ajima, Eba and Nwaokorie, Chukwunonso and Kangkum, Naanma and Ameyan, Lola and Ogefere, Obruche Sophia and Aigbogun, Eric and Amasiatu, Valentine and Igbokwe, Uchenna},
title = {Establishing Sustainable Access to Quality Uterotonics in Kano, Lagos and Niger States—A Supply Chain Perspective},
journal = {The International Journal of Health Planning and Management},
year = {2025},
doi = {10.1002/hpm.3910}
}
EUVIMED